Point-of-care CD4 technology invalid result rates in public health care settings across five countries
Katherine Lamp(Clinton Health Access Initiative), Lara Vojnov(World Health Organization), Divine Nzuobontane(Clinton Health Access Initiative), Charles Kiyaga(Busitema University), Chares Diko Atem, Timothy Bollinger(Clinton Health Access Initiative), Achamyeleh Mulugeta(Ethiopian Public Health Institute), Ilesh Jani(Instituto Nacional de Saúde), Biruhtesfa Abere, Gonfa Ayana(Ethiopian Public Health Institute), Phibeon Munyaradzi Mangwendeza(Centre for Sexual Health and HIV AIDS Research), Sekesai Mtapuri‐Zinyowera(Ministry of Health and Child Welfare), Youyi Fong(Fred Hutch Cancer Center), Jilian A. Sacks(World Health Organization), Nádia Sitoe(Instituto Nacional de Saúde), Trevor Peter(Clinton Health Access Initiative), Seth McGovern(Clinton Health Access Initiative), Adisu Kebede(Ethiopian Public Health Institute), Jean Bosco Elat Nfetam(National Radiation Protection Agency of Cameroon), Naoko Doi(Tokushima Municipal Hospital), George Senyama
Cited by 3
Related Papers
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
|Science|2022|1.2k
A Microchip CD4 Counting Method for HIV Monitoring in Resource-Poor Settings
|PLoS Medicine|2005|195
Muscle RING-Finger Protein-1 (MuRF1) as a Connector of Muscle Energy Metabolism and Protein Synthesis
|Journal of Molecular Biology|2007|165
The WHO public health approach to HIV treatment and care: looking back and looking ahead
|The Lancet Infectious Diseases|2017|119